Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »
Aug 1, 2009 (Vol. 29, No. 14)

High-Throughput Nanovolume qPCR

Next-Generation Platform Combines Microarray Throughput with Sensitivity

  • Smartchip Research Programs

    The SmartChip system is currently being used in gene-expression research at the University of Pittsburgh Medical Center and the University of Texas Southwestern Medical Center. These research programs are designed to identify and validate therapeutically relevant gene-expression biomarkers in chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, lung cancer, and wound healing. 

    Additionally, a SmartChip genotyping research collaboration has been established with scientists in the Institute for Genome Sciences and Policy at Duke University Medical Center. The focus of this program is the validation of SNPs that are related to breast cancer as well as an examination of the impact that validated SNPs have on patients’ disease prognosis and response to treatment. 



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »